Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection

Nature Communications

Volumn 6, Issue , 2015, Pages

  Hao, Xing Pei ^a   Lucero, Carissa M ^a   Turkbey, Baris ^b   Bernardo, Marcelino L ^b   Morcock, David R ^a   Deleage, Claire ^a   Trubey, Charles M ^a   Smedley, Jeremy ^a,c   Klatt, Nichole R ^c   Giavedoni, Luis D ^d   Kristoff, Jan ^e,f   Xu, Amy ^e,g   Del Prete, Gregory Q ^a   Keele, Brandon F ^a   Rao, Srinivas S ^h   Alvord, W Gregory ⁱ   Choyke, Peter L ^b   Lifson, Jeffrey D ^a   Brenchley, Jason M ^h   Apetrei, Cristian ^e,g   Pandrea, Ivona ^e,g   Estes, Jacob D ^a   more..

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CD4 ANTIGEN; DEXTRAN SULFATE; LIPOPOLYSACCHARIDE; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL ORGANELLE; DISEASE PREVALENCE; ECOLOGICAL MODELING; EXPERIMENTAL STUDY; HYPOTHESIS TESTING; IMMUNE SYSTEM; PATHOGENICITY; PRIMATE; TRANSLOCATION;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CHLOROCEBUS AETHIOPS; CHRONIC INFLAMMATION; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; DISEASE SEVERITY; EXPERIMENTAL COLITIS; FEMALE; IMMUNOSTIMULATION; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; ANIMAL; CHEMICALLY INDUCED; COLITIS; GASTROINTESTINAL TRACT; PATHOLOGY;

AFRICA;

CERCOPITHECUS AETHIOPS; MACACA MULATTA; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; COLITIS; DEXTRAN SULFATE; FEMALE; GASTROINTESTINAL TRACT; MACACA MULATTA; MALE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84939515008     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9020     Document Type: Article

References (63)

1. Hazenberg, M. D. et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17, 1881-1888 (2003).
2. Deeks, S. G. et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104, 942-947 (2004).
3. Somsouk, M. Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS 29, 43-51 (2015).
4. Epple, H. J. et al. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 58, 220-227 (2009).
5. Epple, H. J. et al. Acute HIV infection induces mucosal infiltration with CD4+ and CD8+ T cells, epithelial apoptosis, and a mucosal barrier defect. Gastroenterology 139, 1289-1300 (2010).
6. Kuller, L. H. et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS. Med 5, e203 (2008).
7. Boulware, D. R. et al. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J. Infect. Dis. 203, 1637-1646 (2011).
8. Hunt, P. W. et al. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS 25, 2123-2131 (2011).
9. Pandrea, I. et al. Coagulation biomarkers predict disease progression in SIVinfected nonhuman primates. Blood 120, 1357-1366 (2012).
10. Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371 (2006).
11. Estes, J. D. et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 6, e1001052 (2010).
12. Clarke, T. B., Francella, N., Huegel, A. & Weiser, J. N. Invasive bacterial pathogens exploit TLR-mediated downregulation of tight junction components to facilitate translocation across the epithelium. Cell Host Microbe 9, 404-414 (2011).
13. Pandrea, I. & Apetrei, C. Where the wild things are: pathogenesis of SIV infection in African nonhuman primate hosts. Curr. HIV/AIDS Rep. 7, 28-36 (2010).
14. Marchetti, G., Tincati, C. & Silvestri, G. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin. Microbiol. Rev. 26, 2-18 (2013).
15. Pandrea, I. et al. Cutting edge: experimentally induced immune activation in natural hosts of simian immunodeficiency virus induces significant increases in viral replication and CD4+ T cell depletion. J. Immunol. 181, 6687-6691 (2008).
16. Kristoff, J. et al. Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication. J. Clin. Invest. 124, 2802-2806 (2014).
17. Turner, J. R. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9, 799-809 (2009).
18. Funderburg, N. T. et al. Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation. Immunology 140, 87-97 (2013).
19. Pasternak, B. A. et al. Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis. Inflamm. Bowel Dis. 16, 856-869 (2010).
20. Pastor Rojo, O. et al. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm. Bowel Dis. 13, 269-277 (2007).
21. Perse, M. & Cerar, A. Dextran sodium sulphate colitis mouse model: traps and tricks. J. Biomed. Biotechnol. 2012, 718617 (2012).
22. Okayasu, I. et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98, 694-702 (1990).
23. Hunt, P. W. et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J. Infect. Dis. 210, 1228-1238 (2014).
24. Somsouk, M. et al. Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS 29, 43-51 (2015).
25. Kotler, D. P., Gaetz, H. P., Lange, M., Klein, E. B. & Holt, P. R. Enteropathy associated with the acquired immunodeficiency syndrome. Ann. Intern. Med. 101, 421-428 (1984).
26. Brenchley, J. M. & Douek, D. C. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 1, 23-30 (2008).
27. Wakita, M. Behavioral economic analysis of water intake in a laboratory rhesus macaque. Primates 45, 267-270 (2004).
28. National Research Council (U.S.). Committee on Animal Nutrition. & National Research Council (U.S.). Panel on Nonhuman Primate Nutrition. Nutrient Requirements of Nonhuman Primates (National Academy Press, 2003).
29. Geboes, K. et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47, 404-409 (2000).
30. Klatt, N. R. et al. Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL- 17 production in the absence of SIV infection. Mucosal Immunol. 3, 387-398 (2010).
31. Raffatellu, M. et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat. Med. 14, 421-428 (2008).
32. Klase, Z. et al. Dysbiotic bacteria translocate in progressive SIV infection. Mucosal Immunol. doi:10.1038/mi.2014.128 (2015).
33. Aychek, T., Vandoorne, K., Brenner, O., Jung, S. & Neeman, M. Quantitative analysis of intravenously administered contrast media reveals changes in vascular barrier functions in a murine colitis model. Magn. Reson. Med. 66, 235-243 (2011).
34. McLaren, W. J., Anikijenko, P., Thomas, S. G., Delaney, P. M. & King, R. G. In vivo detection of morphological and microvascular changes of the colon in association with colitis using fiberoptic confocal imaging (FOCI). Dig. Dis. Sci. 47, 2424-2433 (2002).
35. Lewis, M., Yanny, S. & Malcolm, P. N. Advantages of blood pool contrast agents in MR angiography: a pictorial review. J. Med. Imaging Radiat. Oncol. 56, 187-191 (2012).
36. Prince, M. R. et al. Gadolinium-enhanced magnetic resonance angiography of abdominal aortic aneurysms. J. Vasc. Surg. 21, 656-669 (1995).
37. Sabach, A. S. et al. Gadofosveset trisodium: abdominal and peripheral vascular applications. AJR Am. J. Roentgenol. 200, 1378-1386 (2013).
38. Hadizadeh, D. R. et al. Simultaneous MR arteriography and venography with blood pool contrast agent detects deep venous thrombosis in suspected arterial disease. AJR Am. J. Roentgenol. 198, 1188-1195 (2012).
39. Paiardini, M. et al. Perturbations of cell cycle control in T cells contribute to the different outcomes of simian immunodeficiency virus infection in rhesus macaques and sooty mangabeys. J. Virol. 80, 634-642 (2006).
40. Dunham, R. et al. The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus. Blood 108, 209-217 (2006).
41. Silvestri, G. et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic highlevel viremia. Immunity 18, 441-452 (2003).
42. Rey-Cuille, M. A. et al. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J. Virol. 72, 3872-3886 (1998).
43. Broussard, S. R. et al. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J. Virol. 75, 2262-2275 (2001).
44. Pandrea, I. et al. High levels of SIVmnd-1 replication in chronically infected Mandrillus sphinx. Virology 317, 119-127 (2003).
45. Marchetti, G. et al. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 22, 2035-2038 (2008).
46. Wirtz, S., Neufert, C., Weigmann, B. & Neurath, M. F. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2, 541-546 (2007).
47. Wirtz, S. & Neurath, M. F. Mouse models of inflammatory bowel disease. Adv. Drug Deliv. Rev. 59, 1073-1083 (2007).
48. Fournier, B. M. & Parkos, C. A. The role of neutrophils during intestinal inflammation. Mucosal Immunol. 5, 354-366 (2012).
49. Xavier, R. J. & Podolsky, D. K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434 (2007).
50. Smedley, J. et al. Tracking the luminal exposure and lymphatic drainage pathways of intravaginal and intrarectal inocula used in nonhuman primate models of HIV transmission. PloS One 9, e92830 (2014).
51. Canary, L. A. et al. Rate of AIDS progression is associated with gastrointestinal dysfunction in simian immunodeficiency virus-infected pigtail macaques. J. Immunol. 190, 2959-2965 (2013).
52. Sereti, I. et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 10, e1003890 (2014).
53. Tabb, B. et al. Reduced inflammation and lymphoid tissue immunopathology in rhesus macaques receiving anti-tumor necrosis factor treatment during primary simian immunodeficiency virus infection. J. Infect. Dis. 207, 880-892 (2013).
54. Del Prete, G. Q. et al. Effect of suberoylanilide hydroxamic acid (SAHA) administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-infected indian rhesus macaques. Antimicrob. Agents Chemother. 58, 6790-6806 (2014).
55. Friedrich, C. et al. Magnetic resonance enterography with and without biphasic contrast agent enema compared to conventional ileocolonoscopy in patients with Crohn's disease. Inflamm. Bowel Dis. 18, 1842-1848 (2012).
56. Schloss, P. D. et al. Introducing mothur: open-source, platformindependent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75, 7537-7541 (2009).
57. Quince, C., Lanzen, A., Davenport, R. J. & Turnbaugh, P. J. Removing noise from pyrosequenced amplicons. BMC Bioinformatics 12, 38 (2011).
58. Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C. & Knight, R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-2200 (2011).
59. White, J. R., Nagarajan, N. & Pop, M. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput. Biol. 5, e1000352 (2009).
60. Pandrea, I. et al. Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys: a new model for the study of SIV pathogenesis in natural hosts. J. Virol. 80, 4858-4867 (2006).
61. Pandrea, I. et al. Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys. J. Virol. 79, 6249-6259 (2005).
62. Pandrea, I. et al. Simian immunodeficiency virus SIVagm dynamics in African green monkeys. J. Virol. 82, 3713-3724 (2008).
63. Giavedoni, L. D. Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology. J. Immunol. Methods 301, 89-101 (2005).